Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

SHE:301096 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Revenue Revenue Growth	709.72	677.99	801.92	1,017	607.41	374.31
Revenue Growth	-0.73%	-15.46%	-21.18%	67.51%	62.27%	80.61%
Gross Profit Gross Profit Growth	288.74	261.28	412.83	665.28	409.23	251.78
Operating Income Operating Income Growth	-45.27	-82.6	-45.73	261.04	122.37	111.36
Net Income Net Income Growth	-51.39	-90.4	-52.74	271.97	194.16	111.09
Earnings Per Share EPS Growth	-0.47	-0.83	-0.49	2.51	1.79	1.37
EPS Growth	-	-	-	40.22%	30.66%	92.96%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
China China Growth	677.54	801.6	1,017	607.41	374.31
Overseas Overseas Growth	0.45	0.33	-	-	-
Total Total Growth	677.99	801.92	1,017	607.41	374.31

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Investments Cash & Investments Growth	456.51	372.6	511.97	881.93	1,239	2,013
Total Debt Total Debt Growth	1,010	872.82	711.99	370.64	8.84	282.7
Net Cash (Debt) Net Cash Growth	-553.69	-500.22	-200.02	511.29	1,230	1,730
Net Cash Growth	-	-	-	-58.43%	-28.92%	-
Net Cash Per Share Net Cash Per Share Growth	-5.09	-4.59	-1.86	4.72	11.34	21.34

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-91.47	-154.64	-195.86	90.45	259.41	145.42
Capital Expenditures CapEx Growth	-98.41	-97.92	-395.1	-688.6	-591.58	-248.45
Free Cash Flow Free Cash Flow Growth	-189.88	-252.56	-590.96	-598.15	-332.16	-103.02
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Gross Margin	40.68%	38.54%	51.48%	65.39%	67.37%	67.27%
Operating Margin	-6.38%	-12.18%	-5.70%	25.66%	20.15%	29.75%
Pretax Margin	-7.20%	-13.44%	-4.50%	29.06%	31.43%	31.78%
Profit Margin	-7.24%	-13.33%	-6.58%	26.73%	31.97%	29.68%
FCF Margin	-26.75%	-37.25%	-73.69%	-58.79%	-54.68%	-27.52%

Dividends

Chart

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.300	0.800	0.600
Dividend Per Share Growth	-62.50%	33.33%	-
Dividend Yield	0.46%	1.19%	0.72%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
PE Ratio	-	-	-	26.07	38.06	83.65
Forward PE	-	116.61	12.33	21.10	26.68	-
PS Ratio	5.78	9.14	5.13	6.97	12.17	24.83

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error